192 related articles for article (PubMed ID: 32431666)
21. Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC-MS/MS based metabolomics approach.
Hosseinkhani S; Salari P; Bandarian F; Asadi M; Shirani S; Najjar N; Dehghanbanadaki H; Pasalar P; Razi F
BMC Endocr Disord; 2022 Jul; 22(1):186. PubMed ID: 35864499
[TBL] [Abstract][Full Text] [Related]
22. Relationship Between Acylcarnitine and the Risk of Retinopathy in Type 2 Diabetes Mellitus.
Wang WY; Liu X; Gao XQ; Li X; Fang ZZ
Front Endocrinol (Lausanne); 2022; 13():834205. PubMed ID: 35370967
[TBL] [Abstract][Full Text] [Related]
23. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
El-Lebedy D; Raslan HM; Mohammed AM
Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.
Zhou H; Zhang C; Ni J; Han X
BMC Endocr Disord; 2019 Oct; 19(1):98. PubMed ID: 31601203
[TBL] [Abstract][Full Text] [Related]
26. Correlation of Serum Acylcarnitines with Clinical Presentation and Severity of Coronary Artery Disease.
Deda O; Panteris E; Meikopoulos T; Begou O; Mouskeftara T; Karagiannidis E; Papazoglou AS; Sianos G; Theodoridis G; Gika H
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327546
[TBL] [Abstract][Full Text] [Related]
27. Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes.
Ottosson F; Smith E; Melander O; Fernandez C
J Clin Endocrinol Metab; 2018 Aug; 103(8):3060-3069. PubMed ID: 29788285
[TBL] [Abstract][Full Text] [Related]
28. Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study.
García-Fontana B; Morales-Santana S; Díaz Navarro C; Rozas-Moreno P; Genilloud O; Vicente Pérez F; Pérez del Palacio J; Muñoz-Torres M
Talanta; 2016; 148():135-43. PubMed ID: 26653434
[TBL] [Abstract][Full Text] [Related]
29. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
[TBL] [Abstract][Full Text] [Related]
30. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum.
Wang M; Yang R; Dong J; Zhang T; Wang S; Zhou W; Li H; Zhao H; Zhang L; Wang S; Zhang C; Chen W
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():144-51. PubMed ID: 26735710
[TBL] [Abstract][Full Text] [Related]
32. The association of cardiovascular disease with impaired health-related quality of life among patients with type 2 diabetes mellitus.
Tan MC; Ng OC; Wong TW; Hejar AR; Anthony J; Sintonen H
Singapore Med J; 2014 Apr; 55(4):209-16. PubMed ID: 24763837
[TBL] [Abstract][Full Text] [Related]
33. Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes.
Ren Y; Jin N; Hong T; Mu Y; Guo L; Ji Q; Li Q; Yang X; Ji L
Sci Rep; 2016 Nov; 6():36437. PubMed ID: 27805038
[TBL] [Abstract][Full Text] [Related]
34. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases.
Larsson SC; Wallin A; Håkansson N; Stackelberg O; Bäck M; Wolk A
Int J Cardiol; 2018 Jul; 262():66-70. PubMed ID: 29605469
[TBL] [Abstract][Full Text] [Related]
35. Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome.
Bene J; Márton M; Mohás M; Bagosi Z; Bujtor Z; Oroszlán T; Gasztonyi B; Wittmann I; Melegh B
Ann Nutr Metab; 2013; 62(1):80-5. PubMed ID: 23296094
[TBL] [Abstract][Full Text] [Related]
36. Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
Davies A; Wenzl FA; Li XS; Winzap P; Obeid S; Klingenberg R; Mach F; Räber L; Muller O; Matter CM; Laaksonen R; Wang Z; Hazen SL; Lüscher TF
Int J Cardiol; 2023 Oct; 389():131261. PubMed ID: 37574027
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes.
Liu S; Liu J; Weng R; Gu X; Zhong Z
BMC Cardiovasc Disord; 2019 Sep; 19(1):213. PubMed ID: 31521122
[TBL] [Abstract][Full Text] [Related]
38. Untargeted mass spectrometric approach in metabolic healthy offspring of patients with type 2 diabetes reveals medium-chain acylcarnitine as potential biomarker for lipid induced glucose intolerance (LGIT).
Knebel B; Mack S; Lehr S; Barsch A; Schiller M; Haas J; Lange S; Fuchser J; Zurek G; Müller-Wieland D; Kotzka J
Arch Physiol Biochem; 2016 Dec; 122(5):266-280. PubMed ID: 27373781
[TBL] [Abstract][Full Text] [Related]
39. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy DH; Ibrahim AA; Ashmawy IO
Diabetes Metab Syndr; 2018 Sep; 12(5):643-648. PubMed ID: 29673927
[TBL] [Abstract][Full Text] [Related]
40. Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.
Sattar N; Rawshani A; Franzén S; Rawshani A; Svensson AM; Rosengren A; McGuire DK; Eliasson B; Gudbjörnsdottir S
Circulation; 2019 May; 139(19):2228-2237. PubMed ID: 30955347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
